Page last updated: 2024-10-29

indapamide and Chronic Kidney Diseases

indapamide has been researched along with Chronic Kidney Diseases in 2 studies

Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.

Research Excerpts

ExcerptRelevanceReference
"Patients with type 2 diabetes were randomized to perindopril-indapamide (4 mg/1."2.75Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. ( Cass, A; Chalmers, J; Cooper, M; Grobbee, DE; Heerspink, HJ; Mancia, G; Mogensen, CE; Neal, B; Ninomiya, T; Perkovic, V; Woodward, M; Zoungas, S, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heerspink, HJ1
Ninomiya, T1
Perkovic, V1
Woodward, M1
Zoungas, S1
Cass, A1
Cooper, M1
Grobbee, DE1
Mancia, G1
Mogensen, CE1
Neal, B1
Chalmers, J1
Dralova, OV1
Maksimov, ML1
Derbentseva, EA1
Ermolaeva, AS1
Starodubtsev, AK1

Trials

1 trial available for indapamide and Chronic Kidney Diseases

ArticleYear
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.
    European heart journal, 2010, Volume: 31, Issue:23

    Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combinatio

2010

Other Studies

1 other study available for indapamide and Chronic Kidney Diseases

ArticleYear
[Correction of aldosterone level as marker of RAAS dysfunction in patients with arterial hypertension degree II-III and chronic kidney diseases].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:4

    Topics: Aged; Aldosterone; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme In

2011